GLYCOMIMETICS INC Contracts & Agreements
65 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (5)
- Human Resources (36)
- Intellectual Property (2)
- Real Estate (5)
- Uncategorized (3)
- Project Agreement dated January 2, 2024 with Patheon Manufacturing Services LLC, part of Thermo Fisher Scientific (Filed With SEC on March 27, 2024)
- Second Amendment to Lease, dated April 20, 2018, by and between the Registrant and BMR-Medical Center Drive LLC (Filed With SEC on March 27, 2024)
- Amended and Restated Non-Employee Director Compensation Policy, as currently in effect (Filed With SEC on March 27, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 3, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 2, 2023)
- Executive Employment Agreement, dated as of February 10, 2023, by and between the Registrant and Chinmaya Rath (Filed With SEC on May 3, 2023)
- Release Agreement, dated February 13, 2023, by and between the Company and Armand Girard (Filed With SEC on May 3, 2023)
- Transition Agreement dated February 21, 2023, by and between the Company and John Magnani, Ph.D (Filed With SEC on May 3, 2023)
- Consulting Agreement dated March 31, 2023, by and between the Company and John Magnani, Ph.D (Filed With SEC on May 3, 2023)
- Executive Employment Agreement, dated as of February 16, 2022, by and between the Registrant and Bruce Johnson (Filed With SEC on May 3, 2023)
- Third Amendment to Lease Agreement, dated April 19, 2023, by and between GlycoMimetics, Inc. and ARE-Maryland No. 45, LLC (Filed With SEC on April 21, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 29, 2023)
- Executive Employment Agreement, dated as of August 31, 2022, by and between the Registrant and Edwin Rock, M.D (Filed With SEC on November 9, 2022)
- GlycoMimetics, Inc. Amended and Restated 2013 Equity Incentive Plan (Filed With SEC on May 20, 2022)
- Sales Agreement, dated April 28, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on April 28, 2022)
- Consulting Agreement, dated as of August 31, 2021, by and between the Registrant and Rachel King (Filed With SEC on March 3, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 3, 2022)
- GlycoMimetics, Inc. Amended and Restated Inducement Plan dated as of January 21, 2022 (Filed With SEC on March 3, 2022)
- Executive Employment Agreement, effective as of August 3, 2021, by and between the Registrant and Harout Semerjian (Filed With SEC on November 2, 2021)
- Amended and Restated Executive Employment Agreement, effective as of February 19, 2021, by and between the Registrant and Eric Feldman (Filed With SEC on August 5, 2021)
- Sales Agreement, dated October 7, 2020, by and between the Company and Cowen and Company, LLC (Filed With SEC on October 7, 2020)
- Collaboration and License Agreement, dated January 2, 2020, by and between the Registrant and Apollomics (Hong Kong) Limited (Filed With SEC on February 28, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the GlycoMimetics, Inc. Inducement Plan (Filed With SEC on February 28, 2020)
- GlycoMimetics, Inc. Inducement Plan (Filed With SEC on February 28, 2020)
- Description of Certain of Registrants Securities (Filed With SEC on February 28, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Rachel K. King (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Brian M. Hahn (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and John Magnani, Ph.D (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Helen Thackray (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Armand Girard (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of March 1, 2019, by and between the Registrant and Armand Girard (Filed With SEC on May 2, 2019)
- Underwriting Agreement by and among GlycoMimetics, Inc., Jefferies LLC and Cowen and Company, LLC, dated March 20, 2018 (Filed With SEC on March 21, 2018)
- 7,000,000 Shares GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on May 25, 2017)
- 3,300,000 Shares GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 17, 2016)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 29, 2016)
- GLYCOMIMETICS, INC. common Stock (par value $0.001 per share) SALES AGREEMENT (Filed With SEC on March 1, 2016)
- LEASE by and between BMR-MEDICAL CENTER DRIVE LLC, aDelaware limited liability company and GLYCOMIMETICS, INC., a Delawarecorporation TABLE OF CONTENTS (Filed With SEC on July 28, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- GLYCOMIMETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on December 20, 2013)
- LICENSE AGREEMENT (Filed With SEC on October 31, 2013)
- [Number of Shares] GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. 2013EQUITY INCENTIVE PLAN ADOPTED BYTHE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: OCTOBER 25, 2013 EFFECTIVE DATE: [],2013 (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. 2013EMPLOYEE STOCK PURCHASE PLAN ADOPTEDBY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: OCTOBER 25, 2013 (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. 2013EMPLOYEE STOCK PURCHASE PLAN ADOPTEDBY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: [], 2013 (Filed With SEC on October 4, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 4, 2013)
- LICENSE AGREEMENT between GLYCOMIMETICS, INC. and PFIZER INC. dated as of October 7, 2011 Table of Contents (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2013EQUITY INCENTIVE PLAN ADOPTED BYTHE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS:[], 2013 EFFECTIVEDATE: [], 2013 (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC 2003 STOCK INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2003 STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2003 STOCK INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 4, 2013)
- LEASE AGREEMENT (Filed With SEC on October 4, 2013)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 4, 2013)